Ok_老虎社区_美港股上老虎

YunaTuna
2021-12-20

EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022

Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech

EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":693917318,"tweetId":"693917318","gmtCreate":1639960480825,"gmtModify":1639960481037,"author":{"id":3581809523229784,"idStr":"3581809523229784","authorId":3581809523229784,"authorIdStr":"3581809523229784","name":"YunaTuna","avatar":"https://static.tigerbbs.com/6463ed1450c2454bfc57b76274b06418","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/693917318","repostId":2192909178,"repostType":4,"repost":{"id":"2192909178","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639957864,"share":"https://www.laohu8.com/m/news/2192909178?lang=&edition=full","pubTime":"2021-12-20 07:51","market":"us","language":"en","title":"EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192909178","media":"Reuters","summary":"Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech ","content":"<p>Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech&nbsp;and Pfizer&nbsp;for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.</p>\n<p>These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.</p>\n<p>The commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.</p>\n<p>These doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.</p>\n<p>Governments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.</p>\n<p>On Dec. 16, the European Commission had said that it has reached an agreement with Moderna&nbsp;to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-20 07:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech&nbsp;and Pfizer&nbsp;for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.</p>\n<p>These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.</p>\n<p>The commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.</p>\n<p>These doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.</p>\n<p>Governments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.</p>\n<p>On Dec. 16, the European Commission had said that it has reached an agreement with Moderna&nbsp;to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","PFE":"辉瑞","BNTX":"BioNTech SE","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192909178","content_text":"Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech and Pfizer for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.\nThese doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.\nThe commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.\nThese doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.\nGovernments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.\nOn Dec. 16, the European Commission had said that it has reached an agreement with Moderna to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1043,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022

评论（1）

热议股票